Previous 10 | Next 10 |
home / stock / vegpf / vegpf news
The following slide deck was published by Vectura Group plc in conjunction with their 2019 Q4 earnings Read more ...
Vectura Group plc (VEGPF) Q2 2019 Results Earnings Conference Call September 10, 2019, 04:30 AM ET Company Participants Paul Fry - Interim-CEO and CFO Geraldine Venthoye - EVP, Pharmaceutical Development Elizabeth Knowles - Head of IR and Corporate Finance Conference Call Par...
The following slide deck was published by Vectura Group plc in conjunction with their 2019 Q2 earnings Read more ...
The following slide deck was published by Vectura Group plc in conjunction with their 2018 Q4 earnings Read more ...
Vectura Group ( OTCPK:VEGPF ) reports FY revenue growth of 8.4% Y/Y to £160.5M of which Inhaled was £131.1M (+15% Y/Y) & Other (non-inhaled) of £29.4M (-13.5% Y/Y). More news on: Vectura Group plc Read more ...
Vectura Group plc (VEGPF) Q4 2018 Earnings Conference Call March 26, 2019 05:30 AM ET Company Participants James Ward-Lilley - CEO Paul Fry - CFO Conference Call Participants James Gordon - JPMorgan Max Herrmann - Stifel Amy Walker - Peel Hunt Samir Devani - Rx Securiti...
Vectura Group ( OTCPK:VEGPF ): FY GAAP EPS of -13.2p. More news on: Vectura Group plc, Earnings news and commentary, Consumer stocks news, Read more ...
The following slide deck was published by Vectura Group plc in conjunction with their 2018 Q2 earnings Read more ...
Vectura Group Plc (VEGPF) Interim Results Earnings Conference Call September 11, 2018 04:30 ET Executives James Ward-Lilley - CEO Roger Heerman - EVP, Commercial & Business Development Gonzalo de Miquel - EVP, Development & Chief Medical Officer Darren Welsford - Financ...
Vectura Group ( OTCPK:VEGPF -1.5% ) reports H1 revenue growth of 1.4% Y/Y to £79.9M of which Inhaled was £64.7M (+7.1% Y/Y) & Other (non-inhaled) of £15.2M (-17.4% Y/Y). More news on: Vectura Group plc, Read more ...